Davenport AP - Search Results

1

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.

Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. Alexander SPH, et al. Among authors: davenport ap. Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S21-S141. doi: 10.1111/bph.14748. Br J Pharmacol. 2019. PMID: 31710717 Free PMC article. Review.

2

Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.

Davenport AP, O'Reilly G, Molenaar P, Maguire JJ, Kuc RE, Sharkey A, Bacon CR, Ferro A. Davenport AP, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S22-5. doi: 10.1097/00005344-199322008-00008. J Cardiovasc Pharmacol. 1993. PMID: 7509950

3

ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.

Maguire JJ, Davenport AP. Maguire JJ, et al. Among authors: davenport ap. Br J Pharmacol. 1995 May;115(1):191-7. doi: 10.1111/j.1476-5381.1995.tb16338.x. Br J Pharmacol. 1995. PMID: 7647976 Free PMC article.

4

Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.

Maguire JJ, Kuc RE, O'Reilly G, Davenport AP. Maguire JJ, et al. Among authors: davenport ap. Br J Pharmacol. 1994 Sep;113(1):49-54. doi: 10.1111/j.1476-5381.1994.tb16172.x. Br J Pharmacol. 1994. PMID: 7812631 Free PMC article.

5

Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors.

Maguire JJ, Bacon CR, Fujimoto M, Davenport AP. Maguire JJ, et al. Among authors: davenport ap. J Hypertens. 1994 Jun;12(6):675-80. J Hypertens. 1994. PMID: 7963492

6

[125I]-PD151242: a selective radioligand for human ETA receptors.

Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Berryman K, Doherty AM. Davenport AP, et al. Br J Pharmacol. 1994 Jan;111(1):4-6. doi: 10.1111/j.1476-5381.1994.tb14015.x. Br J Pharmacol. 1994. PMID: 8012722 Free PMC article.

7

Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?

Davenport AP, Maguire JJ. Davenport AP, et al. Trends Pharmacol Sci. 1994 Jan;15(1):9-11. doi: 10.1016/0165-6147(94)90120-1. Trends Pharmacol Sci. 1994. PMID: 8140658 Review. No abstract available.

8

ETA receptors predominate in the human vasculature and mediate constriction.

Davenport AP, Kuc RE, Maguire JJ, Harland SP. Davenport AP, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S265-7. J Cardiovasc Pharmacol. 1995. PMID: 8587384

9

Potency of PD155080, an orally active ETA receptor antagonist, determined for human endothelin receptors.

Maguire JJ, Kuc RE, Doherty AM, Davenport AP. Maguire JJ, et al. Among authors: davenport ap. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S362-4. J Cardiovasc Pharmacol. 1995. PMID: 8587415

10

Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments.

Maguire JJ, Kuc RE, Rous BA, Davenport AP. Maguire JJ, et al. Among authors: davenport ap. Br J Pharmacol. 1996 May;118(2):335-42. doi: 10.1111/j.1476-5381.1996.tb15407.x. Br J Pharmacol. 1996. PMID: 8735635 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters